Brief report: two-year control of behavioral symptoms with risperidone in two profoundly retarded adults with autism.
Dartnall
N A
NA
Connecticut Department of Mental Retardation, South Central Region, Wallingford 06492, USA.
Holmes
J P
JP
Morgan
S N
SN
McDougle
C J
CJ
D000328:Adult; D001321:Autistic Disorder / Q000150:complications / Q000188:drug therapy*; D003192:Compulsive Behavior / Q000150:complications / Q000188:drug therapy*; D018492:Dopamine Antagonists / Q000627:therapeutic use*; D005260:Female; D006177:Gynecomastia; D006801:Humans; D008607:Intellectual Disability / Q000150:complications; D008297:Male; D018967:Risperidone / Q000627:therapeutic use*; D012702:Serotonin Antagonists / Q000627:therapeutic use*; D016896:Treatment Outcome; D015430:Weight Gain
D018492:Dopamine Antagonists; D012702:Serotonin Antagonists; D018967:Risperidone